Merck KGaA Missed Consensus Estimates

Merck KGaA (MKKGY) reported earnings of $0.26 per share on revenue of $6.32 billion for the second quarter ended June 2026. The consensus earnings estimate was $0.47 per share. The company missed consensus estimates by 44.68% while revenue grew 5.95% on a year-over-year basis.

Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.